The global burden of tuberculosis mortality in children: a mathematical modelling study

Abstract

SummaryBackgroundTuberculosis in children is increasingly recognised as an important component of the global tuberculosis burden, with an estimated 1 million cases in 2015. Although younger children are vulnerable to severe forms of tuberculosis disease, no age-disaggregated estimates of paediatric tuberculosis mortality exist, and tuberculosis has never been included in official estimates of under-5 child mortality. We aimed to produce a global mortality burden estimate in children using a complementary approach not dependent on vital registration data.MethodsIn this mathematical modelling study, we estimated deaths in children younger than 5 years and those aged 5–14 years for 217 countries and territories using a case-fatality-based approach. We used paediatric tuberculosis notification data and HIV and antiretroviral treatment estimates to disaggregate the WHO paediatric tuberculosis incidence estimates by age, HIV, and treatment status. We then applied systematic review evidence on corresponding case-fatality ratios.FindingsWe estimated that 239 000 (95% uncertainty interval [UI] 194 000–298 000) children younger than 15 years died from tuberculosis worldwide in 2015; 80% (191 000, 95% UI 132 000–257 000) of these deaths were in children younger than 5 years. More than 70% (182 000, 140 000–239 000) of deaths occurred in the WHO southeast Asia and Africa regions. We estimated that 39 000 (17%, 23 000–73 000) paediatric tuberculosis deaths worldwide were in children with HIV infections, with 31 000 (36%, 19 000–59 000) in the WHO Africa region. More than 96% (230 000, 185 000–289 000) of all tuberculosis deaths occurred in children not receiving tuberculosis treatment.InterpretationTuberculosis is a top ten cause of death in children worldwide and a key omission from previous analyses of under-5 mortality. Almost all these deaths occur in children not on tuberculosis treatment, implying substantial scope to reduce this burden.FundingUNITAID, National Institutes of Health, and National Institute for Health Research.

Safety of first year vaccination in children born to mothers with inflammatory bowel disease and exposed in utero to anti‐TNFα agents: a French nationwide population‐based cohort

“…This risk falls down to 25% within the second year of life . Overall, children under 5 years old account for 80% of paediatric tuberculosis mortality …”

Tuberculin conversion and tuberculosis disease in infants and young children from the Drakenstein Child Health Study: A call to action

“…[1,2] Recent modelling studies, however, have estimated that TB is a leading cause of childhood morbidity and mortality, causing ~1 million new cases and 250 000 deaths per year. [2][3][4][5] Approximately 80% of these deaths occur before 5 years of age and many are never diagnosed. [3] Our lack of knowledge regarding paediatric TB is driven by several factors that make diagnosis of children with TB challenging in lowand middle-income countries (LMICs), where most paediatric TB patients reside.…”

“…[2][3][4][5] Approximately 80% of these deaths occur before 5 years of age and many are never diagnosed. [3] Our lack of knowledge regarding paediatric TB is driven by several factors that make diagnosis of children with TB challenging in lowand middle-income countries (LMICs), where most paediatric TB patients reside. Nonspecific symptoms and poor sensitivity of tests or lack of training or capacity for microbiological testing, such as sputum culture and GeneXpert MTB/RIF, hamper diagnosis.…”

“…Children rarely present to TB clinics, so integration Tuberculin conversion and tuberculosis disease in infants and young children from the Drakenstein Child Health Study: A call to action of paediatric TB services with control of other diseases, such as maternal and child health facilities or sick visits for lower respiratory tract infections, is an opportunity to improve detection of paediatric TB. [3] This approach will need to be partnered with a push to improve policy-practice gaps, laboratory infrastructure, use of and adherence to INH prophylaxis, and clinical training to increase paediatric case detection and reduce paediatric mortality in Africa. Such a comprehensive package is essential to reduce the childhood TB burden in Africa and other LMICs.…”

Risk factors, clinico-epidemiological profile of tuberculosis among children attending a tertiary care hospital: a two year study

“…Children represent about 10-11% of all TB cases. 2 Researchers estimate that 67 million children are infected with TB (latent TB) and are therefore at risk of developing disease in the future. India is one of the countries with highest childhood cases of tuberculosis in all clinical types.…”